Search results
Results from the WOW.Com Content Network
After initially being diagnosed with cerebral palsy, a doctor who noticed James' outbreaks of laughter diagnosed him with Angelman syndrome at 2 1/2 years old, Farrell told People.
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need.
"Angelman syndrome shares symptoms and characteristics with other disorders including autism, cerebral palsy and Prader-Willi syndrome," read the Angelman Syndrome Foundation website. "People with ...
At the core of Farrell's new organization and its mission: the actor's 20-year-old son James, who lives with Angelman Syndrome. "I want the world to be kind to James," Farrell told People in an ...
Diagnostic criteria for the disorder were initially established in 1995 in collaboration with the Angelman syndrome Foundation (US); [26] these criteria underwent revision in 2005. [ 27 ] Seizures are a consequence, as is excessive laughter, [ 28 ] which is a major hindrance to early diagnosis.
His group co-discovered that the UBE3A gene was inactivated as the cause of Angelman syndrome, [9] and that deletion of the snoRNAs likely contributes to the Prader-Willi phenotype. [10] In collaboration with Isis (now Ionis) Pharmaceuticals he demonstrated that oligonucleotides could be used to activate the paternal allele of Ube3a in the ...
For premium support please call: 800-290-4726 more ways to reach us
Klann serves on the Scientific Advisory Boards of the Foundation for Angelman Syndrome Therapeutics and Pitt Hopkins Syndrome International Network. He also served on the Fragile X Outcomes Measures Group and the Fragile X Syndrome Research Plan Working Group of the National Institutes of Health.